Brief: Adocia Files Patent On Hydrogen Scaffold For Type 1 Diabetes Treatment
Jan 11 (Reuters) - Adocia ADOC.PA :
* ANNOUNCED ON SATURDAY FILING PATENT ON A HYDROGEN SCAFFOLD
FOR
CELL THERAPY IN THE TREATMENT OF TYPE 1 DIABETES
* HYDROGEL SCAFFOLD CONTAINING PANCREATIC CELLS COULD
RESTORE
GLYCEMIC CONTROL WITHOUT REQUIRING INSULIN INJECTION AND
IMMUNOSUPPRESSANT DRUGS
Source text for Eikon: urn:newsml:reuters.com:*:nBw4yXfNqa
Further company coverage: ADOC.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))
Recent news on Adocia SA
See all newsBrief: Adocia And Vester Finance Sign Shareholder Loan Agreement
Brief: Adocia Sees Challenges With GLP-1, Amylin & Other Metabolic Peptides
Brief: Adocia H1 Operating Income EUR -8.932 Million
Brief: Adocia, Tonghua Dongbao Reports Positive Phase 3 Results For Ultra-Rapid Insulin In T2D
Brief: Adocia And Tonghua Dongbao Announce Final Dosing In Phase 3 Clinical Study Of Biochaperone® Lispro